Ebola virus was detected in samples from a child who died last week, the World Health Organization and Democratic Republic of the Congo’s Ministry of Health announce.
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.
The Scientist Creative Services Team | Jul 30, 2020
Linda Saif will give a historical overview of SARS spillovers from animals to humans, and Neville Sanjana will describe recent work on a SARS-CoV-2 spike protein variant that increases human infectivity.
The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
A model scenario concludes that frequent testing with fast turnaround is key to avoiding campus outbreaks of COVID-19, even if the tests are imperfect.
Reports of the infection—including one death this month—recently shook up social media. But, unlike COVID-19, plague is a disease that countries have more or less got under control.
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Stephen Schwartz, known for his work on the vascular system, is the first person associated with the university to succumb to infection with SARS-CoV-2.
It takes a median of five days after infection to get sick, and patients shed the most coronavirus particles early in the illness, according to two new reports.
